Vimarsana
Biggest News Aggregation in the World

Page 18 - Jonathanw Ayers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jonathanw Ayers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jonathanw Ayers Today - Breaking & Trending Today

Whittier Trust Co. Decreases Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Vimarsana News

Whittier Trust Co. Decreases Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Whittier Trust Co. decreased its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) by 8.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,514 shares of the company’s stock after selling 218 shares during the quarter. Whittier Trust Co.’s holdings in IDEXX Laboratories […]

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by 44 Wealth Management LLC - Vimarsana News

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by 44 Wealth Management LLC

44 Wealth Management LLC decreased its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) by 1.5% during the 4th quarter, HoldingsChannel reports. The fund owned 2,943 shares of the company’s stock after selling 45 shares during the quarter. 44 Wealth Management LLC’s holdings in IDEXX Laboratories were worth $1,938,000 as of its most recent […]

IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results - Vimarsana News

IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results

/PRNewswire/ -- Achieves 11% fourth quarter revenue growth as reported and 10.5% organic, driven by 13% CAG Diagnostics recurring revenue growth (reported and...

IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results - Vimarsana News

IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results

IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results News provided by Share this article WESTBROOK, Maine, Feb. 2, 2021 /PRNewswire/ --  Achieves fourth quarter reported revenue growth of 19% and organic growth of 17%, driven by CAG Diagnostics recurring revenue reported growth of 23% and organic growth of 21% High revenue growth supported by sustained strong global trends in pet healthcare Delivers full year EPS of $6.71, an increase of 37% on a reported basis and 31% on a comparable constant currency basis Strong full year EPS results supported by operating margin expans...